AbbVie (NYSE:ABBV) has managed to keep its market share for its bestselling arthritis therapy, Humira, above 70%, generic ...

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth ...

A new research report from Colliers finds that the role of retail pharmacies has changed over time, moving far beyond roles ...